Thermo Fisher Scientific reported before the opening of the market on Wednesday that its third quarter revenues rose 9 percent year over year, thanks to growth across three of its four business segments.

MDxHealth reported on Thursday that its third quarter revenues rose 23 percent year over year, largely due to a 23 percent increase in services revenues during the quarter.

Danaher on Thursday reported a 23 percent year-over-year increase in third quarter revenues, which included a rise of nearly 25 percent in life sciences revenues and of nearly 30 percent in diagnostics revenues.

October 19, 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (“Mindray”) (300760.SZ) released the third quarter report: sale in the third quarter was 6.613 billion CNY, up 20.25% year on year.

Dublin-based diagnostics firm Trinity Biotech on Thursday reported a 61 percent year-over-year increase in second quarter revenues, driven in part by sales of its PCR viral transport media for SARS-CoV-2 testing.

Biocept reported after the close of the market on Monday that its second quarter revenues increased dramatically year over year, as the cancer diagnostics firm continued its provision of COVID-19 testing.

Co-Diagnostics on Thursday after the close of the market posted a 14 percent year-over-year increase in second quarter revenues on continued demand for its Logix Smart COVID-19 test.

HTG Molecular Diagnostics reported after the close of the market on Thursday that its second quarter revenues bumped up about 5 percent year over year.

Lucira Health reported on Thursday after the close of the market that it had $12.4 million in revenues for the second quarter, the firm's second full quarter of commercial activity.

Berkeley Lights reported on Tuesday an 82 percent increase in second quarter revenues driven by higher consumables and service revenues.